Aurobindo Pharma to attend Bank of America Asia Pacific conference
- Aurobindo Pharma officials to attend Bank of America 2026 Asia Pacific Conference
- Meetings scheduled for September 21, 2026, in Hong Kong from 9:00 am to 5:00 pm HKT
- Format includes both one-on-one and group sessions with investors and analysts
- Company confirms no unpublished price-sensitive information will be discussed
*this image is generated using AI for illustrative purposes only.
Aurobindo Pharma will participate in the Bank of America 2026 Asia Pacific Conference on September 21, 2026. Company officials are scheduled to hold one-on-one and group meetings with investors and analysts in Hong Kong.
The interactions are set to take place between 9:00 am and 5:00 pm (HKT). The company stated that the schedule is subject to change due to exigencies on the part of the investor or the company.
Meeting Details
The firm clarified that no unpublished price-sensitive information (UPSI) is intended to be discussed during these interactions. The notice was signed by B. Adi Reddy, Company Secretary, and filed with the National Stock Exchange of India Limited and BSE Limited on September 11, 2026.
| Date | Time | Event | Type | Location |
|---|---|---|---|---|
| September 21, 2026 | 9:00 am to 5:00 pm (HKT) | Bank of America 2026 Asia Pacific Conference | One-on-One and Group Meetings | Hong Kong |
This engagement follows standard corporate communication practices where companies update stakeholders on operational performance and strategic outlooks without disclosing material non-public information.
Historical Stock Returns for Aurobindo Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.68% | +2.60% | +1.93% | +30.63% | +59.94% | 0.0% |
How might Aurobindo Pharma's strategic updates at the conference influence investor sentiment regarding its generic drug pipeline in the Asia-Pacific region?
What potential impact could the one-on-one meetings with analysts have on the company's stock volatility in the days following the September 21 event?
Will Aurobindo Pharma address any recent regulatory challenges or supply chain disruptions during these group sessions with stakeholders?
15
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
